On May 8, 2004, Novo Nordisk received the Angel Award for its dedication to improving the lives of individuals with diabetes and its unwavering focus on treating and preventing diabetes worldwide. The award was presented at the Los Angeles Chapter of the Juvenile Diabetes Research Foundation's (JDRF) annual gala benefiting the Stem Cell Research Fund.
Along with its work with the JDRF, Novo Nordisk is active in a number of initiatives as part of the company's dedication to social responsibility. The company recently launched the Diabetes Aware campaign with the Entertainment Industry Foundation to educate Americans about the importance of detection, monitoring, and proper management of this chronic, progressive disease.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs